FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

December 2, 2019

Period of Report

November 28, 2019

Accession Number

0001640334-19-002503

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →